Adaptive Pulsed Electric Field Control for Tumor Ablation Heat

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing treatments for cell proliferative diseases, such as surgical intervention, radiation, and chemotherapy, are ineffective for all types of tumors and often cause significant side effects or damage to patients, while irreversible electroporation (IRE) can lead to uncontrolled temperature increases causing adverse effects.

Innovation Solution

A closed-loop, algorithmically controlled electrotherapy (ACE) system that dynamically adjusts the energy delivery profile of pulsed electric fields using real-time feedback to control temperature and induce specific cell death pathways, reducing thermal injury and enhancing immune responses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If irreversible electroporation (IRE) is used to ablate tumors, then tumor cells are killed through membrane destabilization, but uncontrolled temperature increases occur causing thermal injury to surrounding tissues

Engineering Contradiction:
Improvetumor cell death efficacyVSAvoidthermal injury to surrounding tissues
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent implements real-time temperature monitoring during IRE treatment using thermocouples or other temperature sensors positioned near the treatment site. The system continuously feeds temperature data back to the control algorithm, which dynamically adjusts pulse delivery parameters (amplitude, duration, interval) to maintain temperature within safe thresholds while ensuring complete tumor ablation

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The treatment protocol transitions from static, pre-programmed pulse sequences to dynamic, adaptive pulse delivery. The system continuously modifies pulse parameters based on real-time temperature measurements and tissue response, optimizing the balance between achieving complete tumor necrosis and preventing thermal damage to adjacent healthy structures

Inventive Principle:
Principle #15Dynamics

2Reliability

If high energy electrical pulses are delivered to ensure complete tumor ablation, then treatment effectiveness increases, but muscle stimulation and patient discomfort increase

Engineering Contradiction:
Improvetumor ablation completenessVSAvoidmuscle stimulation and patient discomfort
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent systematically varies multiple electrical pulse parameters including amplitude, pulse width, repetition rate, and inter-pulse intervals to identify the optimal combination that achieves complete tumor ablation while minimizing muscle stimulation. By exploring the parameter space, the system finds settings that deliver sufficient energy for necrosis without triggering excessive somatic responses

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The treatment uses periodic pulsed delivery with optimized intervals between pulses to allow tissue recovery and reduce cumulative muscle stimulation. The pulsatile nature of the delivery, combined with adaptive timing based on real-time feedback, maintains therapeutic effectiveness while reducing patient discomfort and unwanted muscle contractions

Inventive Principle:
Principle #19Periodic action

3Reliability

If traditional treatments (surgery, radiation, chemotherapy) are used, then tumor cells are destroyed, but significant side effects and damage to patient occur

Engineering Contradiction:
Improvetumor cell destructionVSAvoidside effects and damage to patient
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent replaces mechanical surgical excision with electrical field-based irreversible electroporation, eliminating the need for physical incisions, sutures, and associated surgical trauma. This substitution achieves equivalent tumor destruction through non-thermal electrical membrane disruption, reducing bleeding, infection risk, and recovery time

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system carefully controls electrical pulse parameters to achieve selective tumor cell death while sparing surrounding healthy tissues. By optimizing voltage, pulse duration, and delivery patterns, the treatment creates a therapeutic window that destroys malignant cells through irreversible membrane permeabilization without causing the systemic toxicity associated with chemotherapy or the collateral damage of radiation

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

ACE effectively controls temperature and induces targeted cell death while minimizing side effects, enabling precise tissue ablation and immune stimulation, even in challenging tumor locations.

Implementation Method 1

Irreversible electroporation (IRE) involves placing electrodes within or near the targeted region to deliver a series of low energy, microsecond electric pulses. These pulses permanently destabilize the cell membranes of the targeted tissue (e.g., tumor), thereby killing the cells.

Methodology Applied
Scientific EffectIrreversible electroporation: Electrical Resistance

Implementation Method 2

Recent work by the inventors has focused on the ablation of unwanted soft tissue (malignant tumors) by application of excessive electrical energy

Methodology Applied
Scientific EffectJoule heating: Joule Heating

Data Source

PatentUS12599429B2Methods for controlling treatment volumes, thermal gradients, muscle stimulation, and immune responses in pulsed electric field treatments
Publication Date: 2026.04.14 NORTH CAROLINA STATE UNIV
  • US12599429B2 patent drawing
  • US12599429B2 patent drawing
  • US12599429B2 patent drawing

AI summary

Pursuant to embodiments of the present invention, a method of performing electronically controlled electrotherapy may include modifying or killing target cells and simultaneously modifying a secondary outcome by delivering electrical pulses and dynamically adjusting an energy delivery profile of the electrical pulses in response to a measurement. The secondary outcome may be a physical outcome, a biological outcome, and/or a systemic outcome.